AstraZeneca PLC ZEGA-FF:Frankfurt Stock Exchange

RT Quote | Exchange | EUR
Last | 04/09/21 CEST
41.40quote price arrow up+0.10 (+0.24%)
52 week range
38.80 - 58.00

...

Loading . . .
  • Open41.20
  • Day High41.60
  • Day Low41.20
  • Prev Close41.30
  • 52 Week High58.00
  • 52 Week High Date06/15/20
  • 52 Week Low38.80
  • 52 Week Low Date03/04/21

Key Stats

  • Market Cap131,109.36M
  • Shares Out2,625.34M
  • 10 Day Average Volume1,135.8
  • Dividend1.15
  • Dividend Yield2.78%
  • Beta
  • YTD % Change0.98

KEY STATS

  • Open41.20
  • Day High41.60
  • Day Low41.20
  • Prev Close41.30
  • 52 Week High58.00
  • 52 Week High Date06/15/20
  • 52 Week Low38.80
  • 52 Week Low Date03/04/21
  • Market Cap131,109.36M
  • Shares Out2,625.34M
  • 10 Day Average Volume1,135.8
  • Dividend1.15
  • Dividend Yield2.78%
  • Beta
  • YTD % Change0.98

RATIOS/PROFITABILITY

  • EPS (TTM)1.00
  • P/E (TTM)41.40
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date02/25/2021
  • Div Amount0.95
  • Split Date-
  • Split Factor-

Related Video

VIDEO11:1411:14
The race to vaccinate low-income nations

Profile

MORE
AstraZeneca PLC is a biopharmaceutical company. It focuses on discovery and development of products, which are then manufactured, marketed and sold. It focuses on three main therapy areas: Oncology, Cardiovascular, Renal & Metabolic (CVRM) and Respiratory, while selectively pursuing therapies in Autoimmunity, Infection and Neuroscience. In CVRM, it is expanding its portfolio into the cardiovascular-renal area with roxadustat, as well as investing to explore the benefits of...
Leif Johansson
Non-Executive Chairman
Pascal Soriot
Chief Executive Officer
Marc Dunoyer
Chief Financial Officer
Ruud Dobber
Executive Vice President
Menelas Pangalos
Executive Vice President
Address
1 Francis Crick Avenue
Cambridge
CB2 0AA
United Kingdom